From pioneering Cologuard to developing new blood-based cancer detection tests, Exact Sciences, now abbottglobal , is pushing the boundaries of early cancer screening. I traveled to Madison to sit down with former CEO Kevin Conroy to talk about the company's impact, the promise of early detection, and what comes next. Watch our full conversation at the link in my bio. #AbbottPartner